Abstract:A progressive degradation of the brain's structure and function, which results in a reduction in cognitive and motor skills, characterizes neurodegenerative diseases (NDs) such as Alzheimer's disease (AD), Parkinson's disease (PD), Amyotrophic lateral sclerosis (ALS), and Huntington's disease (HD). The morbidity linked to NDs is growing, which poses a severe threat to human being's mental and physical ability to live well. The gut-brain axis (GBA) is now known to have a crucial role in the emergence of NDs. The gut microbiota is a conduit for the GBA, a two-way communication system between the gut and the brain. The myriad microorganisms that make up the gut microbiota can affect brain physiology by transmitting numerous microbial chemicals from the gut to the brain via the GBA or neurological system. The synthesis of neurotransmitters, the immunological response, and the metabolism of lipids and glucose have all been demonstrated to be impacted by alterations in the gut microbiota, such as an imbalance of helpful and harmful bacteria. In order to develop innovative interventions and clinical therapies for NDs, it is crucial to comprehend the participation of the gut microbiota in these conditions. In addition to using antibiotics and other drugs to target particular bacterial species that may be a factor in NDs, this also includes using probiotics and other fecal microbiota transplantation to maintain a healthy gut microbiota. In conclusion, the examination of the GBA can aid in understanding the etiology and development of NDs, which may benefit the improvement of clinical treatments for these disorders and ND interventions. This review indicates existing knowledge about the involvement of microbiota present in the gut in NDs and potential treatment options.

Connecting the Gut Microbiota and Neurodegenerative Diseases: the Role of Bile Acids

Implications of Gut Microbiota in Neurodegenerative Diseases

Gut Microbiota Mediates Neuroinflammation in Alzheimer’s Disease: Unraveling Key Factors and Mechanistic Insights

Molecular mechanism and therapeutic strategy of bile acids in Alzheimer's disease from the emerging perspective of the microbiota-gut-brain axis

Gut microbiota, pathogenic proteins and neurodegenerative diseases

The clinical and mechanistic roles of bile acids in depression, Alzheimer's disease, and stroke

Expert Insights: The Potential Role Of The Gut Microbiome-Bile Acid-Brain Axis In The Development And Progression Of Alzheimer'S Disease And Hepatic Encephalopathy

Gut microbiota: the indispensable player in neurodegenerative diseases

Gut-brain axis through the lens of gut microbiota and their relationships with Alzheimer's disease pathology: Review and recommendations

Gut Microbiota Regulation and Their Implication in the Development of Neurodegenerative Disease

Gut–Brain Axis as a Pathological and Therapeutic Target for Neurodegenerative Disorders

Therapeutic Prospect of New Probiotics in Neurodegenerative Diseases

Therapeutics for neurodegenerative diseases by targeting the gut microbiome: from bench to bedside

The gut microbiota-brain axis in neurological disorders

Gut Microbiota Mediates Neuroinflammation in Alzheimer's Disease: Unraveling Key Factors and Mechanistic Insights

Gut microbiota-derived short chain fatty acids act as mediators of the gut–brain axis targeting age-related neurodegenerative disorders: a narrative review

Microbiota-Gut-Brain Axis Dysregulation in Alzheimer's Disease: Multi-Pathway Effects and Therapeutic Potential

Effects of Gut Microbiota on Neurodegenerative Diseases

The Relationship Between the Gut Microbiome and Neurodegenerative Diseases

A Review of the Brain-Gut-Microbiome Axis and the Potential Role of Microbiota in Alzheimer's Disease

The contribution of age-related changes in the gut-brain axis to neurological disorders